Position
Squarepoint Ops LLC in LENZ Therapeutics, Inc.
Back to the book · All holders of LENZ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$3.37M$16.00 → $9.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 491.9K | $7.87M | — | — | — | 0.0% |
| Q1 2026 | 1.51M | $13.8M | $9.15 | −$3.37M | $9.28M | 0.0% |